Malignant Anorectal Neoplasm — Trials

Malignant Anorectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 249
Ph III recruiting: 38
Growth YoY: +8.5%
Industry share: 6%
Top sponsor: Fudan University
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (174)

clinicaltrialsPublishedShowing 551–575 of 575 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01129700	Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer	completed	Phase 2	73	National Cancer Center, KoreaOTHER_GOV	1	Apr 27, 2012	clinicaltrials
NCT00689702	Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT)	unknown	Phase 2	43	Institute of Oncology LjubljanaOTHER	1	Mar 26, 2012